(:OBCI)
Business Focus: N/A
Jul 12, 2022 02:17 pm ET
SHAREHOLDER ALERT: Weiss Law Reminds FSTX, STCN, GRRB, and OBCI Shareholders About Its Ongoing Investigations
NEW YORK, July 12, 2022 /PRNewswire/ --
Jul 09, 2022 07:15 pm ET
Lifshitz Law PLLC Announces Investigation of GRRB, OBCI, SRLP, and UBNC
GrandSouth Bancorporation. (OTC: GRRB) Lifshitz Law PLLC announces investigation into possible breach of fiduciary duties in connection with the sale of GRRB to First Bancorp for 0.910 shares of First Bancorp common stock per share of GRRB....
Jun 29, 2022 08:00 am ET
SHAREHOLDER ALERT: Weiss Law Reminds GRRB, OBCI, USWS, and BHVN Shareholders About Its Ongoing Investigations
NEW YORK, June 29, 2022 /PRNewswire/ --
Jun 27, 2022 10:40 pm ET
Equity Alert - The M&A Class Action Firm Announces an Investigation of Ocean Bio-Chem, Inc. - OBCI
NEW YORK, June 27, 2022 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Ocean Bio-Chem, Inc. (OBCI), relating to its proposed acquisition by OneWater Marine Inc. Under the terms of the agreement, OBCI shareholders will receive $13.08 in cash per share they own. Click here for more information: https://www.mon
Jun 27, 2022 11:51 am ET
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: USA Truck, Inc. (Nasdaq - USAK), Zendesk, Inc. (NYSE - ZEN), F-star Therapeutics, Inc. (Nasdaq - FSTX), Ocean B
Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ([email protected]) or Marc Ackerman ([email protected]) at 855-576-4847. There is no...
Jun 22, 2022 04:10 pm ET
SHAREHOLDER ALERT: Weiss Law Investigates Ocean Bio-Chem, Inc.
NEW YORK, June 22, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Ocean Bio-Chem, Inc. ("Ocean Bio" or the "Company") (NASDAQ: OBCI), in connection with the proposed acquisition of the Company and its affiliate, Star Brite Europe, Inc., by OneWater Marine Inc. (NASDAQ: ONEW). Under the terms of the merger agreement, the Company's shareholders will receive $13.08 in cash for each share of Ocean Bio common stock owned. The transaction is valued at approximately $125 million.
Jun 22, 2022 01:21 pm ET
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ocean Bio-Chem, Inc. (Nasdaq - OBCI), U.S. Well Services, Inc. (Nasdaq - USWS), GrandSouth Bancorporation. (OTC
Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ([email protected]) or Marc Ackerman ([email protected]) at 855-576-4847. There is no...
Jun 22, 2022 07:00 am ET
OneWater Marine Inc. Signs Definitive Agreement to Acquire Ocean Bio-Chem, Inc.
OneWater Marine Inc. (NASDAQ: ONEW) (“OneWater” or the “Company”) announced today that it has signed a definitive agreement to acquire Ocean Bio-Chem, Inc. (NASDAQ: OBCI) (“OBCI” or “Ocean Bio-Chem”), a leading supplier and distributor of...
May 16, 2022 09:45 am ET
Ocean Bio-Chem, Inc. Announces First Quarter 2022 Financial Results
Star brite Inc. Parent Company Reports First Quarter Net Sales of $12.7 Million and Net Income of $1.3 Million
Mar 31, 2022 09:15 am ET
Ocean Bio-Chem, Inc. Reports Fourth Quarter and Full Year 2021 Net Sales, Net Income, and Earnings per Share
Star brite parent announces net sales of $64.3 million highest in company history—15.7% higher than 2020—and net income of $8.4 million
Feb 28, 2022 09:00 am ET
OCEAN BIO-CHEM, INC. ANNOUNCES A 33 PERCENT INCREASE IN REGULAR QUARTERLY DIVIDEND
FORT LAUDERDALE, Fla., Feb. 28, 2022 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI), the premier manufacturer and distributor for specialty chemicals in the marine, automotive, recreational vehicle and home care markets, today announced that the Company's Board of Directors approved a quarterly regular dividend increase of 33 percent and declared a regular quarterly dividend of $0.04 per share on the Company's Common Stock. The Company will now pay an annual regular dividend of $0.16 per share. The dividend is payable on March 25, 2022, to the Company's Common Stock Shareholders on reco
Jan 18, 2022 08:00 am ET
Ocean Bio-Chem, Inc. Reports Another Quarter and Year of Record Net Sales for Q4 and Full Year 2021
FORT LAUDERDALE, Fla., Jan. 18, 2022 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today record net sales for both the fourth quarter and the full year 2021, continuing a 9-year trend of record-breaking sales.
Nov 15, 2021 08:00 am ET
Ocean Bio-Chem, Inc. Reports Third Quarter and Nine Month Financial Results for 2021
FORT LAUDERDALE, Fla., Nov. 15, 2021 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI), a leader in performance and appearance chemicals, released its third quarter 2021 financial results today.
Aug 16, 2021 03:40 pm ET
Ocean Bio-Chem, Inc. Announces Record Six Month 2021 Financial Results and NMDA Platinum Supplier of the Year Award
FORT LAUDERDALE, Fla., Aug. 16, 2021 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI), the parent company of Star brite, Inc. and Kinpak Inc.—vertical manufacturer and distributor of performance, appearance, maintenance, and disinfectant chemicals for the marine, RV, and outdoor industries—is pleased to announce its record financial results for the first six months of 2021.
Jul 27, 2021 10:00 am ET
Ocean Bio-Chem, Inc. Reports Record Net Sales for the First Six Months of 2021--23% Increase
FORT LAUDERDALE, Fla., July 27, 2021 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI), the parent company of Star brite, Inc. and Kinpak, Inc.—vertical manufacturer and distributor of performance, appearance, maintenance, and disinfectant chemicals for the marine, RV, and outdoor industries—is pleased to announce sales for the second quarter and the first six months of 2021.
Jun 22, 2021 10:00 am ET
PERFORMACIDE® Kills Virus Causing COVID-19 In Just 30 Seconds
FORT LAUDERDALE, Fla., June 22, 2021 /PRNewswire/ -- OdorStar Technology, LLC. a subsidiary of Ocean Bio-Chem, Inc. (NASDAQ: OBCI), announces it has received approval from The U.S. Environmental Protection Agency (EPA) for its PERFORMACIDE® brand of disinfectants (EPA Reg No. 87508-3) that include a 30-second kill claim for SARS-CoV-2, the virus that causes COVID-19.
Feb 02, 2021 08:00 am ET
Ocean Bio-Chem, Inc. (OBCI) Subsidiary, Kinpak Inc, Announces $5 Million Expansion of its Manufacturing & Distribution Facility in Montgomery, AL
FORT LAUDERDALE, Fla., Feb. 2, 2021 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI), the parent company of Star brite, Inc. and Kinpak Inc. —makers of marine, RV, and outdoor performance and maintenance chemicals—announced today that its subsidiary Kinpak Inc. plans to expand its manufacturing and distribution facilities by an additional 69,000 sq. ft. on its 23-acre site. This planned expansion will bring the total facility square footage to exceed 370,000 sq. ft. of dedicated space for production, warehousing, and distribution. This is the second major expansion of their facilities in
Jan 19, 2021 07:45 am ET
Ocean Bio-Chem, Inc. Reports Record Net Sales for both the Fourth Quarter and the Full Year of 2020, both up 32%
FORT LAUDERDALE, Fla., Jan. 19, 2021 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today record net sales for both the fourth quarter and the full year 2020. For the fourth quarter of 2020, net sales were approximately $12.9 million, compared to approximately $9.7 million for the fourth quarter of 2019, an increase of approximately 32% or $3.2 million.
Nov 23, 2020 08:00 am ET
Ocean Bio-Chem, Inc. Board Authorizes Up to $3 Million Share Common Stock Repurchase Program
FORT LAUDERDALE, Fla., Nov. 23, 2020 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today that its Board of Directors has unanimously authorized a program to repurchase shares of the Company's Common Stock, par value $0.01 per share (the "Common Stock") constituting, in the aggregate, up to an amount not to exceed $3.0 million. The program is effective immediately. Shares of the Common Stock may be repurchased in the open market or through negotiated transactions. The program may be terminated or suspended at any time at the discretion of the Company. The Company may in the fu
Nov 16, 2020 07:30 am ET
Ocean Bio-Chem, Inc. Reports Record Third Quarter and Nine Month Financial Results for 2020
FORT LAUDERDALE, Fla., Nov. 16, 2020 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today record net income for both the third-quarter and the first nine months of 2020.
Oct 19, 2020 09:00 am ET
Ocean Bio-Chem, Inc. Reports Record Net Sales
FORT LAUDERDALE, Fla., Oct. 19, 2020 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today record net sales for both the third quarter and first nine months of 2020. For the third quarter 2020, net sales were approximately $19.2 million, compared to approximately $12.5 million for the third quarter of 2019, an increase of approximately $6.7 million or 53%.
Aug 03, 2020 01:15 pm ET
Ocean Bio-Chem Expands Production of COVID-19 Approved Disinfectant Performacide®
FORT LAUDERDALE, Fla., Aug. 3, 2020 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today that its subsidiary, Kinpak Inc., has commissioned a third production line for the manufacturing of its disinfectant/sanitizer product group Performacide®. Performacide® is an EPA-registered disinfectant that kills the SARS-CoV-2 virus, the cause of COVID-19, on hard surfaces.
Jul 14, 2020 09:00 am ET
Ocean Bio-Chem, Inc. Reports Record Net Sales for both the Second Quarter, 44% increase and the First Six Months of 2020, 18% increase
FORT LAUDERDALE, Fla., July 14, 2020 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today record net sales for the second quarter and the first six months of 2020. For the second quarter of 2020, net sales were approximately $15.7 million, compared to approximately $10.9 million for the second quarter of 2019, an increase of approximately 44% or $4.8 million. For the first six months of 2020, net sales were approximately $23.5 million, compared to approximately $20.0 million for the first six months of 2019, an increase of approximately 18% or $3.5 million.
May 27, 2020 12:00 pm ET
Ocean Bio-Chem, Inc. Announces Annualized - Regular Cash Dividend of $0.08 per/share, and Special Dividend of $0.02 per/share
FORT LAUDERDALE, Fla., May 27, 2020 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI), is pleased to announce the Board of Directors unanimously voted to declare a regular annual dividend of $0.08 per share of common stock, payable quarterly at $0.02 per share.
May 15, 2020 09:45 am ET
Ocean Bio-Chem, Inc. Reports First Quarter 2020 Results
FORT LAUDERDALE, Fla., May 15, 2020 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today its first quarter 2020 financial results.
Apr 27, 2020 01:30 pm ET
Ocean Bio-Chem, Inc. Granted Additional Patent from U.S. Patent and Trademark Office for Disinfectant/Sanitizer Pouch Delivery System for Performacide®
FORT LAUDERDALE, Fla., April 27, 2020 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI), has announced that its wholly owned subsidiary has been granted an additional patent for the Company's Disinfectant Pouch Delivery System with Fluid Control, which is used for delivery of the Company's Performacide® product. This new design patent supplements our existing patents.
Mar 30, 2020 09:00 am ET
Ocean Bio-Chem, Inc. Reports Record Year Net Sales, Income and Earnings per Share In 2019
FORT LAUDERDALE, Fla., March 30, 2020 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced its full year and fourth quarter 2019 financial results.
Mar 19, 2020 12:30 pm ET
Ocean Bio-Chem, Inc. Announces Expansion of Production Capacity for Performacide®, which is on the EPA's List N: Disinfectants for Use Against SARS-CoV-2
FORT LAUDERDALE, Fla., March 19, 2020 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI), has announced that its subsidiary manufacturing plant, Kinpak Inc. in Montgomery, Alabama has increased its number of shifts and is actively hiring additional personnel to try and meet overwhelming demand for its disinfectant product Performacide®. In addition, they have taken steps to expand overall production capacity with the purchase of additional equipment. Performacide® is an EPA-registered disinfectant and sanitizer that is proven to kill previously known strands of human Coronavirus, and meet
Nov 14, 2019 09:00 am ET
Ocean Bio-Chem, Inc. Reports Third Quarter and Nine Month Financial Results
FORT LAUDERDALE, Fla., Nov. 14, 2019 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today its financial results for the third quarter and the first nine months of 2019.
Aug 14, 2019 09:45 am ET
Ocean Bio-Chem, Inc. Reports Second Quarter and Six Month 2019 Results
FORT LAUDERDALE, Fla., Aug. 14, 2019 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today its financial results for the second quarter and first six months of 2019.
May 15, 2019 10:00 am ET
Ocean Bio-Chem, Inc. Reports First Quarter 2019 Results
FORT LAUDERDALE, Fla., May 15, 2019 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today its first quarter 2019 financial results.
Mar 29, 2019 03:30 pm ET
Ocean Bio-Chem, Inc. Reports 2018 Full Year and Fourth Quarter Net Income and Net Sales
FORT LAUDERDALE, Fla., March 29, 2019 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced its full year and fourth quarter 2018 financial results.
Mar 26, 2019 09:00 am ET
Ocean Bio-Chem, Inc. Announces Special Cash Dividend of $0.05 per/share
FORT LAUDERDALE, Fla., March 26, 2019 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI), is pleased to announce the Board of Directors unanimously voted on March 22, 2019 to declare a special cash dividend of $0.05 per share. The dividend is payable April 19, 2019, to holders of record of the Company's Common Stock on April 05, 2019.
Nov 19, 2018 07:20 am ET
Investor Expectations to Drive Momentum within Ocean Bio-Chem, Gaming Partners International, Pershing Gold, OHA Investment, Ohr Pharmaceuticals, and J. W. Mays — Discovering Underlying Factors of Inf
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Ocean Bio-Chem, Inc. (NASDAQ:OBCI), Gaming Partners International...
Nov 14, 2018 08:15 am ET
Ocean Bio-Chem, Inc. Reports Record Third Quarter Net Sales and 49% Increase in Third Quarter Net Income
FORT LAUDERDALE, Fla., Nov. 14, 2018 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today its financial results for the third quarter and the first nine months of 2018.
Aug 14, 2018 09:50 am ET
Ocean Bio-Chem, Inc. Reports Record Second Quarter 2018 Net Income and Net Sales
FORT LAUDERDALE, Fla., Aug. 14, 2018 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today its financial results for the second quarter of 2018. Second quarter 2018 net income of approximately $1.1 million was a second quarter record for the Company and an increase of approximately $169,000, or 18%, compared to net income of approximately $953,000 for the second quarter of 2017. Net income per share in the second quarter of 2018 was $0.12, as compared to net income of $0.10 per share in the second quarter of 2017.
Aug 06, 2018 10:30 am ET
Ocean Bio-Chem, Inc. Announces the Acquisition of Snappy Marine, Inc.
FORT LAUDERDALE, Fla., Aug. 6, 2018 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) subsidiary Star brite Distributing, Inc. announces the acquisition of Snappy Marine, Inc. a leading manufacturer and distributor of teak care products, for the marine industry.
May 15, 2018 10:00 am ET
Ocean Bio-Chem, Inc. Reports Record First Quarter Sales of $8.4 Million; and Net Income of $523,000 and Diluted EPS of $0.06 for the First Quarter of 2018
FORT LAUDERDALE, Fla., May 15, 2018 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today its first quarter 2018 financial results.
Apr 02, 2018 09:45 am ET
Ocean Bio-Chem, Inc. Reports 2017 - Full Year and Fourth Quarter Net Income and Net Sales
FORT LAUDERDALE, Fla., April 2, 2018 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced its full year and fourth quarter 2017 financial results.
Mar 21, 2018 10:30 am ET
Ocean Bio-Chem Declares Special Cash Dividend: $0.06 per/share
FORT LAUDERDALE, Fla., March 21, 2018 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI), announced today that its Board of Directors declared a special cash dividend of $0.06 per share, payable on April 16, 2018 to shareholders of record on April 2, 2018.
Jan 17, 2018 09:00 am ET
Ocean Bio-Chem, Inc. Reports Record 2017 & Fourth Quarter 2017 Net Sales and Prospects for 2018
FORT LAUDERDALE, Fla., Jan. 17, 2018 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today record 2017 net sales of approximately $38.9 million, compared to approximately $36.2 million for the full year of 2016, an increase of $2.7 million or 7.5%. For the fourth quarter of 2017, record net sales were approximately $9.0 million compared to $8.5 million for comparative fourth quarter of 2016.
Nov 14, 2017 10:15 am ET
Ocean Bio-Chem, Inc. Reports Third Quarter and Nine Month Financial Results
FORT LAUDERDALE, Fla., Nov. 14, 2017 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today its third quarter 2017 and first nine months of 2017 financial results.
Aug 21, 2017 10:45 am ET
Ocean Bio-Chem, Inc. Record Sales and Income for Six Month. Record sales increase 18% to $18.3 million. Net income up to $1.5 million, $0.16 per share ---- Additional Comments by CEO Peter Dornau
FORT LAUDERDALE, Fla., Aug. 21, 2017 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ OBCI) announced for the six months ended June 30, 2017, net income was approximately $1,456,000, or $0.16 per common share, compared to net income of approximately $116,000, or $0.01 per common share, for the same period in 2016, an increase of approximately $1,340,000. The net income for the first six months of 2017 constitutes a Company record for the first six months of the year, 40% higher than the Company's previous record first half results in 2011.
Aug 14, 2017 10:30 am ET
Ocean Bio-Chem, Inc. Reports Record Net Income of $953,000, Increase of 45% and Record Net Sales of $9.9 million for the Second Quarter
FORT LAUDERDALE, Fla., Aug. 14, 2017 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ OBCI) announced today record second quarter 2017 net income of approximately $953,000, or $0.10 per common share, compared to net income of approximately $657,000, or $0.07 per common share, for the second quarter of 2016, an increase of approximately $296,000 or 45%. The 2017 second quarter net income is the highest second quarter net income in the Company's history.
Jul 24, 2017 10:45 am ET
Ocean Bio-Chem, Inc. Reports Record Nets Sales for the Second Quarter and the First Six Months of 2017
FORT LAUDERDALE, Fla., July 24, 2017 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today record net sales for the second quarter and the first six months of 2017. For the second quarter of 2017, net sales were approximately $9.9 million, compared to approximately $8.7 million for the second quarter of 2016, an increase of approximately 14% or $1.2 million. For the first six months of 2017, net sales were approximately $18.3 million, compared to approximately $15.5 million for the first six months of 2016, an increase of approximately 18% or $2.8 million.
May 15, 2017 10:30 am ET
Ocean Bio-Chem, Inc. Reports Record First Quarter Net Sales of $8.4 Million; Also Reports Net Income of $504,000 and Diluted EPS of $0.05
FORT LAUDERDALE, Fla., May 15, 2017 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today its first quarter 2017 financial results.
Apr 24, 2017 11:30 am ET
Ocean Bio-Chem, Inc. Reports Record First Quarter- Net Sales
FORT LAUDERDALE, Fla., April 24, 2017 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today record first quarter net sales. For the first quarter of 2017 net sales were approximately $8.4 million, compared to approximately $6.8 million for the first quarter of 2016, an increase of approximately 24% or $1.6 million.
Apr 17, 2017 10:00 am ET
Ocean Bio-Chem, Inc. Announces Special Cash Dividend of $0.06 per/share - Second Consecutive Year for Special Dividend
FORT LAUDERDALE, Fla., April 17, 2017 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) is pleased to announce the Board of Directors unanimously voted on April 13, 2017 to declare for the second consecutive year a special cash dividend of $0.06 per share payable May 11, 2017, to holders of record of the Company's Common Stock on April 27, 2017.
Mar 31, 2017 09:45 am ET
Ocean Bio-Chem, Inc. Reports 2016 Net Income of $2.1 Million and EPS of $0.23 Per Share
FORT LAUDERDALE, Fla., March 31, 2017 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today its 2016 financial results.
Feb 13, 2017 10:30 am ET
Ocean Bio-Chem, Inc. Announces EPA Approval For Labeling Use Of PERFORMACIDE® Hard Surface Disinfectant
FORT LAUDERDALE, Fla., Feb. 13, 2017 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today that its label amendment on PERFORMACIDE® Hard Surface Disinfectant has been accepted by the EPA, to include the additional usage sites of hydroponic and indoor horticulture operations, as well as infused product facilities. PERFORMACIDE®® Hard Surface Disinfectant EPA Reg. No. 87508-3 is a chlorine dioxide based mold & mildew eliminator that does not leave any residue on surfaces after it has dried.
Feb 02, 2017 10:30 am ET
PERFORMACIDE® Hard Surface Disinfectant is EPA registered for killing Norovirus in schools, cafeterias, colleges, day care centers, hotels, and public eating places
FORT LAUDERDALE, Fla., Feb. 2, 2017 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today: With the recent outbreaks of Norovirus causing school closures, the CDC has published guidelines including the recommendation of cleaning and disinfecting contaminated surfaces with a disinfectant registered as effective against Norovirus by the Environmental Protection Agency (EPA). PERFORMACIDE® Hard Surface Disinfectant is EPA registered for killing Norovirus in schools, cafeterias, colleges, day care centers, hotels, and public eating places.
Dec 06, 2016 09:30 am ET
PERFORMACIDE® meets the Center for Disease Control and Prevention recommendations for the Environmental Control of Candida auris
FORT LAUDERDALE, Fla., Dec. 6, 2016 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today the Center for Disease Control and Prevention (CDC) recently announced that drug resistant Candida auris infections have been identified in hospitals in the United States. The CDC report went on to state that C. auris infections tends to occur in hospitalized patients and can be resistant to antifungal drugs. In the announcement, the CDC recommended thorough daily and after-discharge cleaning of rooms of C. auris patients using EPA registered hospital disinfectants active against fungi.
Nov 14, 2016 08:15 am ET
Ocean Bio-Chem, Inc. Reports Record Third Quarter Financial Results
FORT LAUDERDALE, Fla., Nov. 14, 2016 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today its third quarter 2016 financial results.
Aug 15, 2016 10:00 am ET
Ocean Bio-Chem, Inc. Reports Record Second Quarter Net Income of $657,000, an increase of $543,000 over the Second Quarter of 2015
FORT LAUDERDALE, Fla., Aug. 15, 2016 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ OBCI) announced today second quarter net income of approximately $657,000, or $0.07 per common share, compared to approximately $114,000, or $0.01 per common share, for the second quarter of 2015, an increase of $543,000 or approximately 477%. The 2016 period net income constitutes the highest second quarter net income in the Company's history.
May 16, 2016 11:30 am ET
Ocean Bio-Chem, Inc. Reports: 2016 First Quarter Financial Results
FORT LAUDERDALE, Fla., May 16, 2016 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today its financial results for the first quarter of 2016, including first quarter net sales of $6.75 million, a record for the first quarter and $748,000 or 12.5 percent higher than sales of approximately $6 million in the same period in 2015.
Mar 31, 2016 09:30 am ET
Ocean Bio-Chem, Inc. Declares Special Cash Dividend of $0.06 Per Share, 2015 Financial Results Reported
FORT LAUDERDALE, Fla., March 31, 2016 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today that its Board of Directors has declared a special cash dividend of $0.06 per share, payable on April 26, 2016 to holders of record of the Company's common stock on April 12, 2016.
Mar 15, 2016 11:30 am ET
Ocean Bio-Chem, Inc.'s PERFORMACIDE®: The Answer to Kill Viruses and Bacteria at Hospitals, Emergency Rooms, and on Home Care Equipment
FORT LAUDERDALE, Fla., March 15, 2016 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) subsidiary Odorstar Technology, LLC announced that the use of its PERFORMACIDE® disinfectant is an effective disinfectant for use on hard non-porous surfaces that can transfer drug resistant Gram-negative bacterium in medical facilities and on home health care equipment. The Center for Disease Control (CDC) is currently investigating 18 recent deaths in the state of Wisconsin tied to Elizabethkingia anopheles, a Gram-negative bacterium that can cause pneumonia, and blood stream infections. Gram-negati
Mar 09, 2016 01:30 pm ET
Ocean Bio-Chem, Inc. Says Federal Jury Denies False Advertising Claims
FORT LAUDERDALE, Fla., March 9, 2016 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) is pleased to announce that in a lawsuit in the Federal Court, Southern District of Florida, a jury has found that Ocean Bio-Chem's subsidiary, Star brite, did not engage in false advertising concerning its flagship product, Star Tron - Enzyme Fuel Treatment.
Feb 08, 2016 10:00 am ET
Ocean Bio-Chem, Inc.'s Subsidiary - Star brite - Launches Recreational Vehicle Care Line of Products
FORT LAUDERDALE, Fla., Feb. 8, 2016 /PRNewswire/ -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announces the launch of Star brite's new Recreational Vehicle Care product line. These products are specifically formulated to clean, protect and enhance the appearance of recreational vehicles (RV's).
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.